Comparison of first-line bevacizumab in combination with mFOLFOX6 or XELOX in metastatic colorectal cancer

dc.contributor.authors	Bayoglu IV, Yildiz I, Varol U, Cokmert S, Kucukzeybek Y, Alacacioglu A, Demir L, Dirican A, Akyol M, Yildiz Y, Oktay Tarhan M
dc.date.accessioned	2020-02-27T08:42:45Z
dc.date.available	2020-02-27T08:42:45Z
dc.date.issued	2015
dc.identifier.citation	Bayoglu IV, Yildiz I, Varol U, Cokmert S, Kucukzeybek Y, Alacacioglu A, Demir L, Dirican A, Akyol M, Yildiz Y, Oktay Tarhan M (2015). Comparison of first-line bevacizumab in combination with mFOLFOX6 or XELOX in metastatic colorectal cancer. J BUON. , 20(2), 7-460
dc.identifier.uri	https://hdl.handle.net/20.500.12619/66769
dc.title	Comparison of first-line bevacizumab in combination with mFOLFOX6 or XELOX in metastatic colorectal cancer
dc.identifier.volume	20(2)
dc.identifier.startpage	460
dc.identifier.endpage	7
dc.contributor.department	Sakarya Üniversitesi/Tıp Fakültesi/Dahili Tıp Bilimleri Bölümü
dc.contributor.saüauthor	Bayoğlu, İbrahim Vedat
dc.relation.journal	J BUON.
dc.contributor.author	Bayoğlu, İbrahim Vedat